Patents by Inventor Spyridoula Vasileiou

Spyridoula Vasileiou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-COV2-SPECIFIC T CELL COMPOSITIONS AND THEIR USE IN TREATING AND PREVENTING CORONAVIRUS AND OTHER RESPIRATORY VIRUS INFECTIONS
    Publication number: 20230293580
    Abstract: Embodiments of the disclosure concern polyclonal SARS-CoV2 virus specific T cell lines and methods of using the same to treat and prevent viral infections.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 21, 2023
    Inventors: Ann Marie Leen, Spyridoula Vasileiou
  • T CELL PERFORMANCE ASSAY AS A PROGNOSTIC FACTOR FOR CLINICAL OUTCOME
    Publication number: 20230028788
    Abstract: The present disclosure provides, inter alia, compositions and methods for harnessing the immune system (e.g., T cells) as a detection tool to diagnose and predict cancer patient treatment outcomes and for monitoring the persistence of functional, non-genetically modified, T cell therapies in vivo after administration to a subject.
    Type: Application
    Filed: December 18, 2020
    Publication date: January 26, 2023
    Inventors: Wingchi Leung, Premal Lulla, Spyridoula Vasileiou, Ann Marie Leen, Juan F. Vera Valdes